unsorted.txt

July 2021: https://www.nature.com/articles/s41577-021-00550-x is a pretty comprehensive thing on vaccination and the types of immune responses that may or may not be created, how they last, how they impact the virus... but today is not the day I'll be reading it all
https://www.gov.uk/government/publications/long-term-evolution-of-sars-cov-2-26-july-2021  awfully unsettling first scenario out of three, but aside from the scenarioes, the "Background" contains a lot of information some of which is kind of FAQ-answering, like about how "the virus will become milder" is possible in the long term but not at all certain and unlikely in the short term, which keeps coming up, or that re-infection does happen... unfortunately it doesn't provide references for any of these things, so it'll only be good for people who trust the UK government's SAGE group
https://science.sciencemag.org/content/373/6553/397 "Scent of a vaccine" is de-facto's favorite topic of nasal/mucosal vaccines, and if the article is good it may be a good introduction to it
https://www.washingtonpost.com/health/2021/07/29/cdc-mask-guidance/  or https://archive.is/AcvHU (thanks nixonix)  CDC is subtly changing guidance after an internal document, which was leaked and the article contains as a PDF, says that "the war has changed" with Delta

Papers about heterologous vaccination
https://www.medrxiv.org/content/10.1101/2021.06.13.21258859v1 → Immunogenicity and reactogenicity of a heterologous COVID-19 prime-boost vaccination compared with homologous vaccine regimens
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3874014 → Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine by Xinxue Liu, RobertH. Shaw, ArabellaSV Stuart, Melanie Greenland, Tanya Dinesh, Samuel Pro
https://www.medrxiv.org/content/10.1101/2021.07.26.21261130v1  Vaccine effectiveness when combining the ChAdOx1 vaccine as the first dose with an mRNA COVID-19 vaccine as the second dose (probably the first one we saw shown by de-facto)
https://www.nature.com/articles/s41591-021-01449-9  Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination (latest found by xrogaan)


April 2021: https://www.bmj.com/content/373/bmj.n1068 has UK data on vaccine efficacy for the first shot (and second but only for BNT) on around 400000 people. I originally read about it on https://www.bbc.com/news/health-56844220 but the bmj link cites two preprints about it, which I should try to understand because I'm not quite clear on whether the percentages given represent efficacy.
Meanwhile Scotland has something similar at https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00677-2/fulltext and/or https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3789264 (ugh look at which is more recent, or if they are the same, too much stuff in my brain now) which I should check whether it's the continuation of the same study I have in the links from a couple months ago.

https://covid-statistics.jrc.ec.europa.eu/ has dashboard, restrictive measures, and "API" like https://covid-statistics.jrc.ec.europa.eu/api/Measure/getMeasuresGraph/ITA/2020-02-01/2021-03-05/000000000/all
It also has a long list of documents, cfr with https://covid-19-diagnostics.jrc.ec.europa.eu/ already in the list

https://investors.pfizer.com/investor-news/press-release-details/2021/Real-World-Evidence-Confirms-High-Effectiveness-of-Pfizer-BioNTech-COVID-19-Vaccine-and-Profound-Public-Health-Impact-of-Vaccination-One-Year-After-Pandemic-Declared/default.aspx but maybe wait for the study (or get if available) since it looks almost unbelievably good. Try to make sense wrt the strange Danish study https://www.medrxiv.org/content/10.1101/2021.03.08.21252200v1 where there would be *negative* efficacy during the first 14 days, negative by far too, but that's "adjusted" vs "unadjusted" and I certainly didn't get meaningful clarifications about that from https://old.reddit.com/r/COVID19/comments/m2oqc1/realworld_evidence_confirms_high_effectiveness_of/gqloxp1/

https://github.com/ChronicDiseaseEpi/hcw/blob/master/vaccine_manuscript.pdf is a preprint of a Scottish study showing reduced transmission to households of vaccinated healthcare workers

<de-facto> .title https://covid-statistics.jrc.ec.europa.eu/RMeasures
<Brainstorm> de-facto: From covid-statistics.jrc.ec.europa.eu: Measures List - Ecml Covid
<de-facto> CSV at https://www.ecdc.europa.eu/en/publications-data/download-data-response-measures-covid-19
<de-facto> .title https://covidtracker.bsg.ox.ac.uk/
<Brainstorm> de-facto: From covidtracker.bsg.ox.ac.uk: OxCGRT
<de-facto> .title https://ourworldindata.org/policy-responses-covid
<Brainstorm> de-facto: From ourworldindata.org: Policy Responses to the Coronavirus Pandemic - Statistics and Research - Our World in Data
<de-facto> .title https://www.nature.com/articles/s41562-021-01079-8
<Brainstorm> de-facto: From www.nature.com: A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker) | Nature Human Behaviour

Adding on July 11, more things (and some of the same things) about restrictive measures and stringency indexes, also as above, trying to reconstruct what the things we found were:
https://github.com/OxCGRT/covid-policy-tracker
https://ourworldindata.org/grapher/covid-stringency-index?time=2021-07-10
https://covidtracker.bsg.ox.ac.uk/stringency-map
https://covidtracker.bsg.ox.ac.uk/about-api
https://supertracker.spi.ox.ac.uk/ https://supertracker.spi.ox.ac.uk/policy-trackers/ <de-facto> the supertracker also got some i guess